Kids Cancer Alliance

In 2011, the Kids Cancer Alliance (KCA) was developed to accelerate innovations for diagnosis and therapy for children with cancer in NSW.

In 2011, the Kids Cancer Alliance (KCA) was developed to accelerate innovations for diagnosis and therapy including drug discovery and for translation of research into improved care and clinical outcomes for children with cancer in NSW.

The KCA is funded by the Cancer Institute of NSW with significant co-funding by the UNSW Sydney and University of Sydney and brings together a broad group of clinicians and scientists from each of the partners which include

KCA is currently undertaking research projects in diagnostics, therapy, survivorship and models of care that will ultimately lead to improved outcomes in the diagnosis of cancer.

As a consequence of research, major advances in childhood leukaemia therapy have seen survival rates improve from 70% to approximately 85% over the last 30 years.